Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®

Elaine S. DeMeyer, MSN, RN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC and has been a nurse entrepreneur for more than two decades. Elaine leverages her healthcare background along with creativity, business knowledge, and collaborative relationships.

Her mission through beyond Oncology is: To improve patient care by empowering oncology professionals with the tools and resources to change practice.

Articles by Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®

Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 16, 2024
Although CRAB describes end-organ symptoms of multiple myeloma, it does not provide a full picture.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 8, 2024
Myeloma is a complex blood cancer that can be difficult to comprehend, especially the 2 earlier precursor disease stages.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 4, 2024
Oncology nurses have a central role in glycemia control, beginning with a clear assessment of glucose blood levels.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 4, 2024
To manage aGVHD, oncology nurses often give high-dose glucocorticoids that can cause steroid-induced hyperglycemia.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 16, 2024
Oncology nurses must be able to quickly identify hypercalcemia because it can cause cardiac arrest or coma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | April 16, 2024
Hypercalcemia is the most common oncologic emergency, which makes it critical to understand this electrolyte imbalance.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 1, 2024
The GI tract, commonly called “the gut,” is a frequent target of GVHD, in particular aGVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 7, 2024
Dealing with the long-term, life-altering, uncomfortable symptoms of chronic GVHD can be difficult to accept.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As the care team members with the most patient contact, oncology nurses must understand shared decision-making.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As patients may be considering or receiving anti-BCMA therapy, oncology nurses need to be able to explain this target.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | February 12, 2024
Muscle cramps are among the lesser-known manifestations of cGVHD, but can have debilitating symptoms.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 7, 2024
Recent studies suggest that up to 75% of patients report muscle cramps and that the cramps can last up to 30 minutes.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | December 18, 2023
Oncology nurses must understand these diverse manifestations and their potential impact on patients’ daily lives. 
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | December 18, 2023
Nearly 1 of 5 patients (18%) with cGVHD had kidney dysfunction, with 8% having moderate-severe dysfunction.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | November 9, 2023
As a trusted profession, oncology nurses are critical in helping women manage genital cGVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | November 10, 2023
Oncology nurses are in a pivotal position to assess for symptoms of female genital cGVHD and to intervene early.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | October 17, 2023
Understanding how patients and caregivers describe their health status is crucial to knowing what matters most to patients.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | October 13, 2023
Different types of secondary solid tumors can occur after allogeneic HSCT, including oral cancer.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | October 17, 2023
There are 5 criteria that you should discuss with your patients if you suspect frailty.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 9, 2024
Exercise, diet, and stress reduction can go a long way to improve patient frailty.